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In Vitro Fertilization (IVF) Cumulative Pregnancy
Rate Prediction from Basic Patient Characteristics
Bo Zhang, Yuqi Cui, Meng Wang, Jingjing Li, Lei Jin and Dongrui Wu,
Abstract—Tens of millions of women suffer from infertility
worldwide each year. In vitro fertilization (IVF) is the best
choice for many such patients. However, IVF is expensive, time-
consuming, and both physically and emotionally demanding. The
first question that a patient usually asks before the IVF is how
likely she will conceive, given her basic medical examination
information. This paper proposes three approaches to predict the
cumulative pregnancy rate after multiple oocyte pickup cycles.
Experiments on 11,190 patients showed that first clustering the
patients into different groups and then building a support vector
machine model for each group can achieve the best overall perfor-
mance. Our model could be a quick and economic approach for
reliably estimating the cumulative pregnancy rate for a patient,
given only her basic medical examination information, well before
starting the actual IVF procedure. The predictions can help the
patient make optimal decisions on whether to use her own oocyte
or donor oocyte, how many oocyte pickup cycles she may need,
whether to use embryo frozen, etc. They will also reduce the
patient’s cost and time to pregnancy, and improve her quality of
life.
Index Terms—In vitro fertilization (IVF), machine learning,
cumulative pregnancy rate prediction
I. INTRODUCTION
According to the World Health Organization (WHO) [33],
infertility is “a disease of the reproductive system defined by
the failure to achieve a clinical pregnancy after 12 months or
more of regular unprotected sexual intercourse.” For women
under 60, infertility was ranked the 5th highest serious global
disability [1]. Estimates from 25 international population sur-
veys sampling 172,413 women indicated that 9% of them
suffered from infertility [5]. Another study [14] on household
survey data from 277 demographic and reproductive health
surveys for women aged 20-44 estimated that 48.5 million
couples worldwide suffered from infertility in 2010. The 2006-
2010 United States National Survey of Family Growth (NSFG)
[7] sampling 22,682 men and women aged 15-44 also found
that 6.0% (1.5 million) women suffered from infertility in
2006-2010.
Assisted reproductive technology (ART) [23] could help
these couples to conceive pregnancy. The most common ART
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is in vitro fertilization (IVF) [8], which retrieves eggs from
a woman’s ovaries, fertilizes them in the laboratory, and
then transfers the resulting embryos into the woman’s uterus
through the cervix. According to the 2015 ART National
Summary Report [2], more than 99% ART cycles performed
in the United States in 2015 used IVF.
The timeline of a typical IVF procedure is shown in Fig. 1.
During the patient’s first visit, initial consultation is conducted,
her medical history is recorded, and basic medical examination
is performed. This process may take 1-2 days. At Day 3,
the patient’s basic characteristics such as age, BMI, infertility
duration, AFC, AMH, FSH, pathogenesis, etc., are available. If
the patient determines to perform IVF, then usually it will take
three menstrual cycles. In the first menstrual cycle, additional
examination and controlled ovarian hyper-stimulation (COH)
are performed. Oocyte pickup and egg fertilization are done
in the second menstrual cycle. Embryo or balstocyst transfer
are performed in the third menstrual cycle. The entire process
takes about 2-3 months. During this process, embryo mor-
phology features can be extracted to determine the embryo
quality, number of embryo to transfer, and the transfer plan,
etc. If the patient fails to conceive after embryo transfer, she
has to spend the same amount of time again to repeat this
procedure, which represents a heavy burden to many patients,
economically, physically, and emotionally.
Cumulative pregnancy rate, which tells the probability that
a patient conceives pregnancy after multiple IVF cycles, is an
important measure for evaluating different IVF approaches,
and is usually also the first question that a patient asks before
starting the IVF. Given the long duration (2-3 months) and
high cost of an IVF cycle (the average cost of an IVF cycle
is approximately $10,000-15,000 in the United States [12],
and $4,500 in Tongji Hospital in China), it is important to be
able to accurately estimate the individualized cumulative preg-
nancy rate, so that the patient can make the most appropriate
decisions on whether to use her own oocyte or donor oocyte,
how many oocyte pickup cycles she may need, whether to use
embryo frozen, etc. Artificial intelligent, particularly machine
learning [4], could be used for this purpose.
Machine learning has rapidly progressed the medical field
during the past few years. It has been used to predict the
development of hepatocellular carcinoma [21], adult autism
spectrum disorder [30], non-small cell lung cancer prognosis
[32], human oocyte developmental potential [31], the risk of
acute myeloid leukaemia [3], etc., and also to identify a human
neonatal immune-metabolic network associated with bacterial
infection [22], to classify skin cancer [9], to isolate individual
cell for scalable molecular genetic analysis of single cells [6],
2Fig. 1. The IVF timeline. Our model utilizes only the basic medical examination information during the first visit, and it can give the cumulative pregnancy
rate prediction on Day 3 when the initial medical examination results are ready. Conventional approaches in the literature use information during the actual
IVF to predict the pregnancy rate, and hence are much more time-consuming and expensive than our approach.
and so on.
Machine learning has also been used to predict the preg-
nancy result with features obtained before and during the IVF,
including basic patient characteristics, embryo morphology,
and so on. For example, decision trees [18], [19] have been
used to investigate the relationship between the outcome of
transfer and 53 embryo, oocyte and follicular features [20],
to predict the IVF outcome from 100 variables related to
the basic patient characteristics (e.g., age, body mass index,
etc.) and derived from the different stages of the IVF cycle
(e.g., the amount of hormone treatment, the measurement of
ovary volume, etc.) [17], and to predict the IVF outcome from
69 features on patient’s basic information, diagnosis, clinical
tests, treatment methods, etc [11]. Bayesian classifiers have
been used to select the most promising embryos to transfer
to the woman’s uterus using features related to clinical data
and embryo morphology [16], and to predict implantation
outcome of individual embryos in an IVF cycle from 18
features including age, infertility factor, treatment protocol,
sperm, embryo morphology, etc [25]. Support vector machines
(SVMs) [27] and Bayesian Classifiers [26] have been used
to predict implantation outcomes of new embryos from 17
features related to patient characteristics, clinical diagnosis
treatment method, and embryo morphological parameters.
However, to our knowledge, no one has used only patient
characteristics from basic medical examinations to predict the
cumulative IVF pregnancy rate, as we are doing in this study.
In this paper, we propose supervised and unsupervised
machine learning approaches for cumulative pregnancy rate
prediction from basic patient characteristics. We show that the
approach that integrates unsupervised learning and supervised
learning achieves the best performance. Our approach can sig-
nificantly save the time and cost in predicting the cumulative
IVF pregnancy rate, and thus can help the patients make more
appropriate decisions before the IVF starts.
The remainder of this paper is organized as follows: Sec-
tion II introduces our three machine learning approaches for
cumulative pregnancy rate prediction. Section III presents the
experimental results. Section IV discusses the benefits of our
proposed approaches. Finally, Section V draws conclusion.
II. OUR PROPOSED MACHINE LEARNING APPROACHES
This section introduces the dataset used in our study,
and the feature selection and machine learning approaches
for cumulative pregnancy rate prediction from basic patient
characteristics.
A. The Dataset
This study consisted of 11,190 Chinese couples who suf-
fered from infertility and received IVF treatments at Tongji
Hospital (ranked 3rd in Gynaecology and Obstetrics in China),
Huazhong University of Science and Technology, Wuhan,
China, between January 2016 and March 2018. Their IVF
cycles varied from one to 11, as summarized in Table I. Only
basic patient characteristics obtained from the initial medical
examination were used in our prediction, which included fe-
male age, female body mass index (BMI), infertility duration,
antral follicle count (AFC), anti-mullerian hormone (AMH),
follicle-stimulating hormone (FSH), and 30 pathogeny factors.
B. Feature Selection
In order to select the most informative features, we per-
formed logistic regression [13] using all basic patient char-
acteristics, where each categorical feature was converted to a
binary value using one-hot encoding. We used only Cycle 1
pregnancy results as the labels for logistic regression, and
excluded patients who did not receive a transfer in Cycle 1.
3TABLE I
SUMMARY OF BASIC PATIENT CHARACTERISTICS IN OUR STUDY. THE
FIRST SIX FEATURES ARE NUMERICAL. THEIR MEANS AND STANDARD
DEVIATIONS ARE CALCULATED. PATHOGENY HAS 30 FACTORS. FOR EACH
FACTOR, THE NUMBER OF PATIENTS AND THE PERCENTAGE ARE GIVEN.
THE 11 USED FEATURES ARE MARKED BY ASTERISKS.
Cycle Statistics
Cycle 1 n=9,419
Cycle 2 n=1,432
Cycle 3 n=236
Cycle 4 n=59
Cycle 5 n=30
Cycle 6 n=7
Cycle 7 n=2
Cycle 8 n=2
Cycle 9 n=2
Cycle 10 n=0
Cycle 11 n=1
Total n=11,190
Patient Characteristics
Female age (years)* 31.5 ± 5.22
Female BMI (kg/m2)* 21.85 ± 2.90
Infertility duration (years)* 3.64 ± 2.98
Antral follicle count (AFC)* 12.93 ± 7.08
Anti-mullerian hormone (AMH) (ng/ml)* 4.95 ± 4.07
Follicle-stimulating hormone (FSH) (IU/L)* 7.94 ± 3.12
Pathogeny:
Ovulatory dysfunction n=53 (0.5%)
Polycystic ovary syndrome (PCOS)* n=1,123 (10.0%)
Abnormal uterine bleeding (AUB) n=1 (0.0%)
Hypogonadolropic hypogonadism (HH) n=17 (0.2%)
Kallmann syndrome n=0 (0.0%)
Hyperprolactinemia n=55 (0.5%)
Pituitary adenoma n=16 (0.1%)
Panhypopituitarism n=0 (0.0%)
Empty sella syndrome (ESS) n=0 (0.0%)
Diminished ovarian reserve (DOR)* n=1,512 (13.5%)
Premature ovarian insufficiency (POI) n=2 (0.0%)
Perimenopause* n=641 (5.7%)
Pelvic inflammatory disease (PID) n=1,326 (11.8%)
Tubal obstruction n=2,451 (21.9%)
Hydrosalpinx n=388 (3.5%)
Salpingitis n=2,306 (20.6%)
Pelvic tuberculosis n=48 (0.4%)
Endometriosis n=494 (4.4%)
Chocolate cyst n=372 (3.3%)
Adenomyoma n=239 (2.1%)
Uterine malformation n=182 (1.6%)
Intrauterine adhesion* n=417 (3.7%)
Scarred uterus n=857 (7.6%)
Myoma n=460 (4.1%)
Endometritis n=20 (0.1%)
Endometrial tuberculosis n=21 (0.1%)
Endometrial hyperplasia (EH) n=4 (0.0%)
Chromosome abnormality n=208 (1.9%)
Paternal factor* n=3,253 (29.1%)
Others n=37 (0.3%)
Multiple logistic regression analyses showed that 14 features
had significant correlation with pregnancy results (P < 0.01).
Among them, three etiological factors (endometrial tubercu-
losis, chromosome abnormality, and others) had fewer than
2% of the total patients. They were removed to make the
features more representative. As a result, 11 features were
finally selected for further analysis, and they are marked by
asterisks in Table I.
C. Cumulative Pregnancy Rate Prediction
The prediction of IVF outcome is extremely difficult using
only basic patient characteristics without controlled ovar-
ian hyper-stimulation details, and embryo and endometrial
features. According to previous research, embryo features
are very important for the final outcome prediction using
machine learning [11], [15]. When using only basic patient
characteristics, we assume that patients having similar basic
characteristics also have similar pregnancy rates. This is the
best assumption we could make before starting the actual
IVF. When the patients start the IVF, more features could be
extracted, and more individualized prediction could be made.
However, these features are not available before the IVF, and
hence will not be used in our model.
We constructed three different machine learning models –
clustering, SVM, and clustering-SVM (C-SVM), and com-
pared their performances using three measures. The pipeline
of our three machine learning approaches is shown in Fig. 2.
Only the 11 asterisk features in Table I were used. We first
used one-hot encoding to convert each categorical feature into
numerical features, and then performed z-normalization to
transform each feature to have mean 0 and standard deviation
1.
D. Model 1: Clustering
In the training phase of the clustering approach, we first
applied k-means clustering with k = 30 to all patients. We
then identified all possible 30 × 29/2 = 435 unique pairs of
clusters. For each pair, we performed the log-rank test [10],
[24], [29] between the two clusters to check if the difference
between them was significant. If the p value of at least one of
the 435 tests was larger than a predefined threshold α (α =
0.01 was used in our study), then we identified the two clusters
with the largest p-value (which meant the two clusters were the
most similar) and merged them. We repeated the log-rank tests
with the remaining clusters, until all p-values were smaller
than α. We then recorded the center of each cluster, and its
corresponding cumulative pregnancy rate.
In the testing phase, when the basic characteristics of a new
patient came in, we assigned the patient to the cluster with the
closest centroid, and then used the corresponding cumulative
pregnancy rate as the prediction.
E. Model 2: SVM
For the SVM classifier [28], we first performed 5-fold
cross validation on the training set to search for the best
kernel function (polynomial, RBF, or linear) and to determine
whether a larger weight should be used to accommodate the
minority class. Eventually we used the RBF kernel and set the
per-class weights inversely proportional to class frequencies in
the training data. We then used penalty parameter C = 1 to
train a probabilistic SVM classifier.
F. Model 3: C-SVM
The C-SVM approach was a sequential combination of the
clustering approach and the SVM approach. In the training
phase, it first used the clustering approach to group the patients
into several clusters, and then trained an RBF SVM for each
cluster to individualize the patients within each cluster.
4Fig. 2. Pipeline of the three proposed machine learning approaches. Given a training dataset of patients with basic medical examination information, all three
models use the 11 asterisk features in Table I, convert the categorical features to numerical features using one-hot encoding, and z-normalize each feature.
Clustering is an unsupervised approach. SVM is a supervised approach. C-SVM integrates both unsupervised and supervised approaches.
In the testing phase, when the basic characteristics of a new
patient came in, we first assigned the patient to the cluster with
the closest centroid, and then used the corresponding SVM to
predict a more individualized cumulative pregnancy rate.
III. PREDICTION RESULTS
This section compares the prediction performances of the
three proposed approaches.
A. Area under the Curve (AUC)
First, we evaluated the performances of the three approaches
by randomly sampling two thirds of the patients as training
data, and the remaining one third as test data. We used the
training data to train the three models and then validated them
on the test data. Their receiver operating characteristic (ROC)
curves are shown in Fig. 3, and the corresponding areas under
the curve (AUCs) were also computed and indicated in the
legend. Fig. 3 shows that SVM and C-SVM had similar AUC
performances (0.69 and 0.70, respectively), both of which were
higher than clustering (AUC=0.67).
B. Cumulative Pregnancy Rate Prediction
Once we get the predicted probability and the correspond-
ing cluster of each patient in test data, we can predict the
cumulative pregnancy rate using the mean probability of the
corresponding cluster. Fig. 4 shows the cumulative pregnancy
rate curve using the three approaches. Although SVM had
promising AUC in Fig. 3, its cumulative pregnancy rate
prediction had large biases. On the other hand, clustering and
C-SVM, particularly C-SVM, had much smaller prediction
errors.
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Fig. 3. ROC curves and AUCs of the three approaches.
C. Stability of the Prediction Models
In order to test the stability of the three prediction models,
we repeated them 30 times, each time with different training
and test data. As Table I shows that less than 1% patients had
more than three cycles, we did not consider cycle numbers
larger than three. The mean and standard deviation of the
AUCs from the 30 runs are shown in the first part of Table II.
On average C-SVM achieved the best AUCs in the three
cycles.
We also studied the stability of the three approaches us-
ing another the root mean squared error (RMSE). For each
model in each run, we concatenated the predicted cumulative
pregnancy rates in three cycles and n clusters into a 3n-
element vector yˆ = [yˆ1, ..., yˆ3n], and computed the RMSE
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Fig. 4. Predicted cumulative pregnancy rate curves of the three models on
test data. (a) Clustering; (b) SVM; (c) C-SVM. The solid curves in the same
color in the three subfigures are identical, indicating the true cumulative
pregnancy rate curve of a cluster. The dashed curves indicate the predictions
from different approaches. In each subfigure, the solid and dashed curves in
the same color indicate results in the same cluster, which should be close.
TABLE II
MEAN AND STANDARD DEVIATION (IN PARENTHESES) OF AUCS AND
RMSES OF THE THREE PROPOSED APPROACHES. THE BEST ONES ARE
MARKED IN BOLD.
Cycle Clustering SVM C-SVM
AUC
1 0.6725 (0.0075) 0.6906 (0.0080) 0.6920 (0.0075)
2 0.6699 (0.0065) 0.6891 (0.0074) 0.6890 (0.0069)
3 0.6684 (0.0063) 0.6865 (0.0075) 0.6866 (0.0076)
RMSE All 0.0274 (0.0098) 0.0794 (0.0130) 0.0267 (0.0096)
between the predictions and the corresponding groundtruth
y = [y1, ..., y3n],
RMSE =
[
1
3n
3n∑
i=1
(yˆi − yi)
2
]1/2
(1)
A smaller RMSE means a better performance. The mean and
std of the RMSEs in the 30 runs are shown in the second part
of Table II. Again, C-SVM achieved the best performance.
We also performed an analysis of variance (ANOVA) test to
check if there was statistically significant difference between
each pair of algorithms. The p-values are shown in Table III,
where the statistically significant ones are marked in bold.
SVM and C-SVM were statistically significantly better than
clustering on AUC, and SVM and C-SVM were statistically
significantly better than clustering on RMSE. In summary, C-
SVM achieved the best overall performance.
TABLE III
p-VALUES OF ANOVA TESTS (α = 0.05) ON THE THREE PROPOSED
APPROACHES.
Clustering SVM
AUC
SVM 0.00
C-SVM 0.00 0.92
RMSE
SVM 0.00
C-SVM 0.97 0.00
IV. DISCUSSIONS
This section discusses the advantages of our proposed
approaches, particulary C-SVM, our best-performing model.
A. C-SVM Reduce the Time and Cost to Predict the IVF
Cumulative Pregnancy Rate
Our C-SVM model uses only the basic medical examination
information during the first visit (which takes two days and
costs about $50 in Tongji Hospital in China) to predict the
cumulative pregnancy rate, and the result can be known
immediately after the visit.
Compared with the conventional approaches in the liter-
ature, which use information during the IVF (which takes
2-3 months and costs about $4,500 in Tongji Hospital in
China), our approach is much faster and more economic. It
significantly saves the patient’s time and cost, and represents a
step towards precision medicine and individualized treatment.
6B. Cumulative Pregnancy Rate Prediction Is More Informative
than Single-Cycle Pregnancy Rate Prediction
The total duration and cost of IVF is significantly impacted
by the number of oocyte pickup cycles. Since oocyte pickup
is time-consuming and expensive, a patient may choose to
freeze the extra embryos from the first oocyte pickup cycle to
reduce the time and cost: the frozen embryos can be transferred
in case previous transfers fail, without the need to pickup
fresh oocyte and fertilize them again. However, frozen embryo
transfer may have a lower pregnancy rate than fresh embryo
transfer. So, it is important to know the cumulative pregnancy
rate of fresh embryo transfers so that the patient can make
a smarter decision on whether it is worthwhile to save the
time and cost of another oocyte pickup cycle. Our C-SVM
model can predict the cumulative pregnancy rates after one,
two or three oocyte pickup cycles, which gives the patients
exact information they need in decision making.
A patient with poor ovarian reserve is very difficult to
conceive using her own oocyte. Knowing the cumulative
pregnancy rate using her own oocyte could greatly help her
make a wiser decision: if the cumulative pregnancy rate
using her own oocyte is much lower than her expectation,
then the patient may choose to receive donor oocyte, which
may have much higher pregnancy rate. In this way, the
patient can avoid potentially multiple controlled ovarian hyper-
stimulations, shorten the time to pregnancy, reduce the overall
cost, and hence improve the quality of life.
V. CONCLUSION
In this paper, we have developed three different approaches
(clustering, SVM, and C-SVM) to predict the IVF cumulative
pregnancy rate in multiple cycles of oocyte pickup using
basic patient characteristic. The selected parameters included
female age, female BMI, infertility duration, AFC, AMH,
FSH, and five pathogeny factors (diminished ovarian reserve,
perimenopause, paternal factor, PCOS, and intrauterine adhe-
sion). Experimental results showed that the AUCs of SVM and
C-SVM were better than that of clustering, and the prediction
RMSEs of clustering and C-SVM were smaller than that of
SVM. In summary, C-SVM seems to be the best model.
To our best knowledge, this is the first study on using
machine learning to predict the cumulative pregnancy rate of
multiple IVF cycles from only basic patient characteristics
before the actual IVF. The predictions can help the patient
make optimal decisions on whether to use her own oocyte or
donor oocyte, how many oocyte pickup cycles she may need,
whether to use embryo frozen, etc. They will also reduce the
patient’s cost and time to pregnancy, and improve her quality
of life.
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